Biological Psychiatry 1989-03-01

1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.

A Hamik, S J Peroutka

Index: Biol. Psychiatry 25(5) , 569-75, (1989)

Full Text: HTML

Abstract

The affinity of 1-(m-chlorophenyl)piperazine (mCPP) for 11 neurotransmitter receptor binding sites was determined in human brain membranes. mCPP is essentially equipotent at all 5-hydroxytryptamine (5-HT) receptor subtypes (IC50 values ranging from 360 to 1300 nM). The drug displays similar affinity (IC50 = 570 nM for alpha 2-adrenergic receptors labeled for 3H-rauwolscine. mCPP is less potent at alpha 1- and beta-adrenergic, dopamine, and muscarinic cholinergic receptors (IC50 values 2500-24,000 nM). mCPP is inactive at both benzodiazepine receptors and the 5-HT uptake sites at concentrations below 100,000 nM. These data demonstrate that mCPP displays similar potency for multiple neurotransmitter receptor binding sites in human brain.


Related Compounds

Related Articles:

N-methyl-D-aspartate receptor channel blocker-like discriminative stimulus effects of nitrous oxide gas.

2015-01-01

[J. Pharmacol. Exp. Ther. 352(1) , 156-65, (2015)]

Simultaneous Quantitation of 78 Drugs and Metabolites in Urine with a Dilute-And-Shoot LC-MS-MS Assay.

2015-06-01

[J. Anal. Toxicol. 39 , 335-46, (2015)]

Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia.

1991-08-01

[Br. J. Pharmacol. 103(4) , 2016-20, (1991)]

Detection of 1-benzylpiperazine and 1-(3-trifluoromethylphenyl)-piperazine in urine analysis specimens using GC-MS and LC-ESI-MS.

2008-01-01

[J. Anal. Toxicol. 32(6) , 444-50, (2008)]

In vitro efficacy of new antiprotozoals against Philasterides dicentrarchi (Ciliophora, Scuticociliatida).

2004-11-23

[Dis. Aquat. Organ. 62(1-2) , 97-102, (2004)]

More Articles...